Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma

PURPOSE: NRG Oncology/RTOG 9802 (ClinicalTrials.gov Identifier: NCT00003375) is a practice-changing study for patients with WHO low-grade glioma (LGG, grade II), as it was the first to demonstrate a survival benefit of adjuvant chemoradiotherapy over radiotherapy. This post hoc study sought to deter...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Bell, Erica H., Zhang, Peixin, Shaw, Edward G., Buckner, Jan C., Barger, Geoffrey R., Bullard, Dennis E., Mehta, Minesh P., Gilbert, Mark R., Brown, Paul D., Stelzer, Keith J., McElroy, Joseph P., Fleming, Jessica l., Timmers, Cynthia D., Becker, Aline P., Salavaggione, Andrea L., Liu, Ziyan, Aldape, Kenneth, Brachman, David G., Gertler, Stanley Z., Murtha, Albert D., Schultz, Christopher J., Johnson, David, Laack, Nadia N., Hunter, Grant K., Crocker, Ian R., Won, Minhee, Chakravarti, Arnab
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7527157/
https://ncbi.nlm.nih.gov/pubmed/32706640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.02983
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados